Patents by Inventor Nissim Garti
Nissim Garti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20090156743Abstract: The present invention discloses a nucleating microemulsion comprising nanovehicles, each comprising an amphiphilic shell surrounding a nucleating agent. The microemulsion is suitable for the delivery of the nucleating agents into a thermoplastic polymer, thereby allowing crystallization of the polymer.Type: ApplicationFiled: February 27, 2007Publication date: June 18, 2009Applicant: Yissum Research Development Company of the Hebrew University of JerusalemInventors: Nissim Garti, Abraham Aserin, Dima Libster
-
Publication number: 20080287551Abstract: The present invention discloses the use of a lycopene coated with a water non-soluble thin film comprising amphiphilic protein polymer for coloring with red color, foods, pharmaceuticals or cosmetics having fat and/or oil contents higher than 5%. The invention further discloses a process for the preparation of stable lycopene formulation comprising (a) treating an isolated protein to form a protein in a molecular form; (b) dispersing lycopene in an aqueous solution comprising an isolated protein in a molecular form; (c) grinding said dispersion to form lycopene particle size of 1 to 10 ?m forming an homogenized mixture comprising fine particles; and optionally (d) drying the homogenized mixture.Type: ApplicationFiled: July 29, 2008Publication date: November 20, 2008Applicant: LYCORED NATURAL PRODUCTS INDUSTRIES LTD.Inventors: Nissim Garti, Morris Zelkha, Tanya Sedlov
-
Patent number: 7390807Abstract: The present invention relates to lamotrigine, a useful agent for anti-epilepsia. New crystal forms of lamotrigine containing molecules of the solvent in stoichiometric ratios are disclosed. The present invention also provides processes for preparing the new crystal forms of lamotrigine.Type: GrantFiled: January 31, 2005Date of Patent: June 24, 2008Assignee: Teva Pharmaceutical Industries Ltd.Inventors: Nissim Garti, Yana Berkovich, Ben-Zion Dolitzky, Judith Aronhime, Claude Singer, Anita Liebermann, Neomi Gershon
-
Publication number: 20080139808Abstract: The present invention relates to lamotrigine, a useful agent for anti-epilepsia. New crystal forms of lamotrigine containing molecules of the solvent in stoichiometric ratios are disclosed. The present invention also provides processes for preparing the new crystal forms of lamotrigine.Type: ApplicationFiled: January 30, 2008Publication date: June 12, 2008Inventors: Nissim Garti, Yana Berkovich, Ben-Zion Dolitzky, Judith Aronhime, Claude Singer, Anita Liebermann, Neomi Gershon
-
Publication number: 20070176143Abstract: The present invention concerns ternary system comprising 40 to 65% water; 6 to 22% alcohol or a ketone; and 25 to 60% a fatty acid or an ester thereof forming spontaneously a stable, non-viscous and clear nanosized structures having cubic-like nanosized symmetry. The ternary system may be dispersed and used as a solubilizing medium for hydrophobic and hydrophilic substances.Type: ApplicationFiled: December 30, 2004Publication date: August 2, 2007Applicant: YISSYM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEMInventors: Nissim Garti, Rivka Efrat, Avraham Aserin
-
Patent number: 7183272Abstract: The present invention provides for new crystal forms of oxcarbazepine, more particularly oxcarbazepine Forms B, C, D and E. The present invention further provides processes for preparation of these forms. Form B is prepared by evaporating the solvents from a solution of oxcarbazepine in toluene and dichloromethane. Form B is also obtained by immediately cooling the solution of oxcarbazepine and toluene. Cooling the same solution at a slower rate, but still fairly rapidly, results in oxcarbazepine Form C. Cooling the same solution at even a slower rate results in another Form, oxcarbazepine Form D. Oxcarbazepine Form E, a solvate of chloroform, is obtained by precipitating a solution of oxcarbazepine and chloroform. The present invention also provides processes for converting one of the newly discovered crystal forms of oxcarbazepine into another crystal form, including Form A, which is in the prior art.Type: GrantFiled: February 12, 2002Date of Patent: February 27, 2007Assignee: Teva Pharmaceutical Industries Ltd.Inventors: Judith Aronhime, Ben-Zion Dolitzky, Yana Berkovich, Nissim Garti
-
Patent number: 7182950Abstract: The present invention relates to nano-sized self-assembled structured concentrates and their use as effective suitable carriers for transferring active components into the human body. The nano-sized self-assembled concentrates are composed of an aqueous phase, an oil phase, a surfactant a co-solvent and co-surfactant. The formed nano-sized self-assembled structured concentrates may be in the form of an aqueous continuous phase, an oil continuous phase or a bicontinuous phase, and may thus be diluted to any desired extent in either oil or water maintaining their structure and the active material comprised within the nano-sized self-assembled structured concentrates.Type: GrantFiled: June 12, 2002Date of Patent: February 27, 2007Assignee: Nutralease Ltd.Inventors: Nissim Garti, Abraham Aserin, Aviram Spernath, Idit Amar
-
Publication number: 20050254319Abstract: The present invention is directed to a 3-dimensional optical memory comprising as an active medium a compound capable of interconverting from one isomeric form to another by interaction of light. Said compound is bound to a polymer for achieving a uniform memory unit.Type: ApplicationFiled: February 20, 2003Publication date: November 17, 2005Applicant: MEMPILE INC.Inventors: Ortal Alpert, Nissim Garti, Elena Panitkova, Andrew Shipway, Thierry Wasserman
-
Publication number: 20050175561Abstract: The present invention discloses the use of a lycopene coated with a water non-soluble thin film comprising amphiphilic protein polymer for coloring with red color, foods, pharmaceuticals or cosmetics having fat and/or oil contents higher than 5%. The invention further discloses a process for the preparation of stable lycopene formulation comprising: (a) treating an isolated protein to form a protein in a molecular form; (b) dispersing lycopene in an aqueous solution comprising an isolated protein in a molecular form; (c) grinding said dispersion to form lycopene particle size of 1 to 10 ?m forming an homogenized mixture comprising line particles; and optionally (d) drying the homogenized mixture.Type: ApplicationFiled: November 26, 2002Publication date: August 11, 2005Applicant: Lycored Natural Products Industries Ltd.Inventors: Nissim Garti, Morris Zelkha, Tanya Sedlov
-
Publication number: 20050171107Abstract: The present invention relates to lamotrigine, a useful agent for anti-epilepsia. New crystal forms of lamotrigine containing molecules of the solvent in stoichiometric ratios are disclosed. The present invention also provides processes for preparing the new crystal forms of lamotrigine.Type: ApplicationFiled: January 31, 2005Publication date: August 4, 2005Inventors: Nissim Garti, Yana Berkovich, Ben-Zion Dolitzky, Judith Aronhime, Claude Singer, Anita Liebermann, Neomi Gershon
-
Patent number: 6861426Abstract: The present invention relates to lamotrigine, a useful agent for anti-epilepsia. New crystal forms of lamotrigine containing molecules of the solvent in stoichiometric ratios are disclosed. The present invention also provides processes for preparing the new crystal forms of lamotrigine.Type: GrantFiled: February 27, 2002Date of Patent: March 1, 2005Assignee: Teva Pharmaceutical Industries Ltd.Inventors: Nissim Garti, Yana Berkovich, Ben-Zion Dolitzky, Judith Aronhime, Claude Singer, Anita Liebermann, Neomi Gershon
-
Patent number: 6706795Abstract: The present invention relates to a method for the production of particles of nano-materials being transition metals and alloys; metal oxides; and ceramic compositions having a small nanosize, i.e. about 1-6 nm. The method comprises a synthesis in the solutions of complex liquids from suitable precursors, which precursors are selected from suitable surfactants and alkoxides, by a suitable chemical reaction under mild conditions; and preparing from said materials fine colloids dispersed in various polymer solutions. The water in the solution is preferably non freezing water, the mild conditions are atmospheric pressure and a temperature range of room temperature to 70° C., and the reaction condition is selected among a hydrolysis, reduction and exchange process.Type: GrantFiled: September 11, 2000Date of Patent: March 16, 2004Assignee: Yissum Research Development Company of the Hebrew University of JerusalemInventors: Nissim Garti, Yana Berkovich
-
Publication number: 20040026812Abstract: A tablet-making apparatus comprising die supports and guide supports fixed upon a base, plunger guides supported by the guide supports, a die having an opening through which powder may be charged, two plunger rods with opposing faces, the rods being horizontally disposed and reciprocally received within the die, and a means for activating the reciprocal movement of the plungers whereby, a tablet may be formed within the die and between the opposing plunger rod faces and then moved to a position to be gravitationally discharged.Type: ApplicationFiled: November 20, 2002Publication date: February 12, 2004Applicant: TIY Inc.Inventors: Eli Pinthus, Nissim Garti, Mordechai Kerzner, Yoram Sela, Chanoch Kotev
-
Publication number: 20030232095Abstract: The present invention relates to nano-sized self-assembled structured concentrates and their use as effective suitable carriers for transferring active components into the human body. The nano-sized self-assembled concentrates are composed of an aqueous phase, an oil phase, a surfactant a co-solvent and co-surfactant. The formed nano-sized self-assembled structured concentrates may be in the form of an aqueous continuous phase, an oil continuous phase or a bicontinuous phase, and may thus be diluted to any desired extent in either oil or water maintaining their structure and the active material comprised within the nano-sized self-assembled structured concentrates.Type: ApplicationFiled: June 12, 2002Publication date: December 18, 2003Applicants: NUTRALEASE LTD., Yissum Research Development CompanyInventors: Nissim Garti, Abraham Aserin, Aviram Spernath, Idit Amar
-
Publication number: 20030228395Abstract: Disclosed are vitamin, mineral and nutrient delivery systems, and in particular beverage and solid food compositions and methods for the enhanced solubilization and delivery of fat-soluble compositions.Type: ApplicationFiled: January 28, 2003Publication date: December 11, 2003Applicant: Archer-Daniels Midland CompanyInventors: Nissim Garti, Lewis G. Jacobs, Branin Lane, Imad Zakharia
-
Publication number: 20030018030Abstract: The present invention relates to lamotrigine, a useful agent for anti-epilepsia. New crystal forms of lamotrigine containing molecules of the solvent in stoichiometric ratios are disclosed. The present invention also provides processes for preparing the new crystal forms of lamotrigine.Type: ApplicationFiled: February 27, 2002Publication date: January 23, 2003Inventors: Nissim Garti, Yana Berkovich, Ben-Zion Dolitzky, Judith Aronhime, Claude Singer, Anita Liebermann, Neomi Gershon
-
Publication number: 20030004154Abstract: The present invention provides for new crystal forms of oxcarbazepine, more particularly oxcarbazepine Forms B, C, D and E. The present invention further provides processes for preparation of these forms. Form B is prepared by evaporating the solvents from a solution of oxcarbazepine in toluene and dichloromethane. Form B is also obtained by immediately cooling the solution of oxcarbazepine and toluene. Cooling the same solution at a slower rate, but still fairly rapidly, results in oxcarbazepine Form C. Cooling the same solution at even a slower rate results in another Form, oxcarbazepine Form D. Oxcarbazepine Form E, a solvate of chloroform, is obtained by precipitating a solution of oxcarbazepine and chloroform. The present invention also provides processes for converting one of the newly discovered crystal forms of oxcarbazepine into another crystal form, including Form A, which is in the prior art.Type: ApplicationFiled: February 12, 2002Publication date: January 2, 2003Inventors: Judith Aronhime, Ben-Zion Dolitzky, Yana Berkovich, Nissim Garti
-
Patent number: 6294686Abstract: The invention provides a method of preparing new crystal forms of aspartame utilizing microemulsions comprising: (a) introducing aspartame into a microemulsion formed from an oil phase, an aqueous phase and at least one emulsifier, (b) destabilizing the microemulsion to effect recrystallization of aspartame; (c) separating solid phase crystals from the liquid phase in which they are contained; and (d) cleaning the crystals to remove traces of the oil phase and surfactant.Type: GrantFiled: June 28, 2000Date of Patent: September 25, 2001Assignee: Yissum Research Development Company of the Hebrew University of JerusalemInventors: Helga F. Milhofer, Nissim Garti, Alexey Kamishny
-
Patent number: 5847109Abstract: An isolated galactomannan having at least 50 repeating units of mannose and galactose in a ration of between 0.5-1.0 and 1.8-1.0, and having a protein content of less than 20 wt. %, a saponin content of less than 5 wt. %, and a lipid content of less than 1 wt. %, which can be used as an active ingredient in nutraceutical and cosmetic products.Type: GrantFiled: November 19, 1996Date of Patent: December 8, 1998Assignee: Yissum Research Development CompanyInventors: Nissim Garti, Abraham Aserin, Zecharia Madar, Boaz Sternheim
-
Patent number: 5837311Abstract: Tomatoes are separated into desirable food products by subjecting them, after conventional preliminary treatments, such as crushing, to a separation of serum from pulp by centrifugation at temperatures between 75.degree. and 110.degree. C. and centrifugal force between 2600 and 4000 G, whereby to obtain a pulp that contains at least 500 ppm of lycopene. The pulp is then subjected to extraction by means of solvents having .delta.H (delta H) and .delta.P (delta P) values chosen so as to extract an oleoresin that has a desired content of lycopene, phospholipids and mono- and di-glycerides. The serum is concentrated and mixed either with dehydrated spent tomato pulp or with dispersing agents and the mixture is dried to produce a new food product which is substantially free from sugars and agrochemicals, is low in lipids, and has a water content less than 5 ww %.Type: GrantFiled: June 21, 1996Date of Patent: November 17, 1998Assignees: Makhteshim Chemical Works Ltd., Makhteshim Agan of North America Ltd.Inventors: Morris Zelkha, Mordechai Ben-Yehuda, Dov Hartal, Yigal Raveh, Nissim Garti